BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17938484)

  • 1. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma.
    Iqbal J; Joshi S; Patel KN; Javed SI; Kucuk C; Aabida A; d'Amore F; Fu K
    Indian J Cancer; 2007; 44(2):72-86. PubMed ID: 17938484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
    Fu K; Iqbal J; Chan WC
    Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in lymphoma diagnosis and management.
    Iqbal J; Liu Z; Deffenbacher K; Chan WC
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA microarrays in lymphoid malignancies.
    Rosenwald A
    Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma.
    Dybkaer K; Iqbal J; Zhou G; Chan WC
    Clin Lymphoma; 2004 Jun; 5(1):19-28. PubMed ID: 15245604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
    Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
    Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
    Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
    J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in diffuse large B-cell lymphoma.
    Morgensztern D; Martin MG; Lossos IS
    Leuk Lymphoma; 2007 Apr; 48(4):669-82. PubMed ID: 17454624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
    Last K; Debarnardi S; Lister TA
    Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.
    Broséus J; Chen G; Hergalant S; Ramstein G; Mounier N; Guéant JL; Feugier P; Gisselbrecht C; Thieblemont C; Houlgatte R
    Oncotarget; 2016 Dec; 7(51):83987-84002. PubMed ID: 27276707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gene expression profiling in lymphoma diagnosis and prognosis.
    Orsborne C; Byers R
    Histopathology; 2011 Jan; 58(1):106-27. PubMed ID: 21261687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
    Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
    Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.